Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$8.29
+0.24%
Mkt Cap $460.19M
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$19.00
Range $19.00 – $19.00
Implied Upside
+129.2%
Consensus $19.00 vs current $8.29
NASDAQ·Healthcare·Biotechnology
$8.29
+0.24%
Mkt Cap $460.19M
No recent rating data.
Price Target (14 analysts)
$19.00
Range $19.00 – $19.00
+129.2%
Consensus $19.00 vs current $8.29